Hematology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Hematology Market is segmented by Product, Reagents (Coagulation Reagents, Flow Cytometry Reagents, Immuno-hematology Reagents, and Other Reagents), Application, End User, and Geography.

Market Snapshot

hematology market
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers.

Blood disorders have become a global health issue with different causes, and are associated with high mortality. Blood disorders, such as anemia, blood cancer, hemorrhagic conditions, and blood infections, affect millions of people each year across all age groups. According to WHO, hemoglobin disorders are potentially affecting 75% of births, globally, and sickle cell trait affects an estimated one in 12 African Americans. Over 70% of all sickle-cell affected births occur in Africa. As per the World Health Organization, the prevalence of anemia in children is 47.4% and 12.7% in men, and it is increasing rapidly all over the world. According to the National Institute of Health (NIH), anemia affects 29% of women with reproductive age and 38% of pregnant women, worldwide.

Hemophilia, a genetic bleeding disorder that prevents the blood from clotting normally, affects one in 5,000 male births. About 400 babies are born with hemophilia, each year, in the United States. The global incidence of hemophilia is observed in more than 400,000 people. The most common blood disorder, venous thromboembolism, affects at least 1 million people in the United States and it is a major cause of death in adults. Leukemia, lymphoma, myeloma, and myelodysplastic syndromes are types of highly prevalent cancers. Approximately every 3 minutes, one person in the United States is diagnosed with a type of blood cancer. The need to address the rising burden of blood disorders is increasing. Early diagnosis and treatment are the best ways to protect the quality of life for a patient with blood cell disorder.

Scope of the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2025. For the purpose of this study, Mordor Intelligence has segmented the global hematology market report on the basis of product, reagent, application, end-user, and region.

By Product
Hematology Analyzers
Flow Cytometers
Coagulation Analyzers
Slide Stainers
Centrifuges
Hemoglobinometers
Other Products
By Reagent
Coagulation Reagents
Flow Cytometery Reagents
Immuno-hematology Reagents
Other Reagents
By Application
Drug Testing
Auto Immune Disease
Cancer
Diabetes Mellitus
Infectious Disease
Other Applications
By End User
Hospitals
Clinical Testing Institutes
Patient Self-testing
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Patient Self-testing Segment, under End User is Expected to Grow at the Fastest Rate, during the Forecast Period

The clinical testing institutes segment held a maximum share in 2019, due to the increasing awareness for hematology testing, shift from manual testing to automated testing, and competitive benefits offered by these providers, as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).

The patient self-testing segment is projected to show significant growth during the forecast period, owing to the growing cases of hematology disorders, such as anemia and iron deficiency, as well as infectious diseases.

hemato 2.png

To understand key trends, Download Sample Report

The North American Region Holds the Largest Market Share of the Hematology Market, and is Expected to Follow the Same Trend over the Forecast Period

Currently, North America is the largest market for hematology analyzers. This market trend can be attributed to the increasing incidence of blood disorders. The increasing cases of blood-related disorders, such as anemia, blood cancer, etc., may lead to the growth of the hematology market.

Asia Pacific is expected to register the fastest CAGR. The rise in per capita income leading to increased adoption of diagnostic and therapy products coupled with government initiatives to improve healthcare infrastructure are expected to fuel the regional market growth.

Hematology Market geo.png

To understand geography trends, Download Sample Report

Competitive Landscape

The global market is highly competitive. Some key industry participants include Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc., Danaher Corporation and F. Hoffmann-La Roche Ltd . The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. For instance, in November 2017, Sysmex acquired CLIA Waiver, for the New Automated Hematology Analyzer.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Blood Disorders and Other Diseases

      2. 4.2.2 Rapid Technological Advances in Hematology

      3. 4.2.3 Emergence of High Throughput Hematology Analyzers

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Instruments

      2. 4.3.2 Low Adoption of Hematology Analyzers in Emerging Economies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Hematology Analyzers

      2. 5.1.2 Flow Cytometers

      3. 5.1.3 Coagulation Analyzers

      4. 5.1.4 Slide Stainers

      5. 5.1.5 Centrifuges

      6. 5.1.6 Hemoglobinometers

      7. 5.1.7 Other Products

    2. 5.2 By Reagent

      1. 5.2.1 Coagulation Reagents

      2. 5.2.2 Flow Cytometery Reagents

      3. 5.2.3 Immuno-hematology Reagents

      4. 5.2.4 Other Reagents

    3. 5.3 By Application

      1. 5.3.1 Drug Testing

      2. 5.3.2 Auto Immune Disease

      3. 5.3.3 Cancer

      4. 5.3.4 Diabetes Mellitus

      5. 5.3.5 Infectious Disease

      6. 5.3.6 Other Applications

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Clinical Testing Institutes

      3. 5.4.3 Patient Self-testing

      4. 5.4.4 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies Inc.

      3. 6.1.3 Bio-Rad Laboratories Inc.

      4. 6.1.4 Danaher Corporation

      5. 6.1.5 Dolomite Centre

      6. 6.1.6 F.Hoffmann-La Roche AG

      7. 6.1.7 Novo Nordisk AS

      8. 6.1.8 Fluidigm Corporation

      9. 6.1.9 Micronit Microfluidics BV

      10. 6.1.10 PerkinElmer Inc.

      11. 6.1.11 Thermo Fisher Scientific Inc.

      12. 6.1.12 uFluidix

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hematology Market market is studied from 2018 - 2026.

The Hematology Market is growing at a CAGR of 5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F.Hoffmann-La Roche AG

Are the major companies operating in Hematology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!